Type 2 Diabetes: What’s the Scientific Evidence for the Role of the Gut Microbiome?
Sponsored by Pendulum Therapeutics
Tuesday, September 28th 8:30 AM CST
If interested in attending the event, please contact the MAND President, Edward Han (firstname.lastname@example.org)
An expanding body of evidence demonstrates that pathophysiologic changes occur in the gut microbiome of people with type 2 diabetes. These changes, along with potential management modalities, including the use of novel probiotics, will be discussed. Presenters include a renowned endocrinologist and a registered dietitian nutritionist, certified diabetes care and education specialist well versed in this science. Sufficient time will be allotted for Q and A.